RhumbLine Advisers’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Buy |
|
|||||
|
2025
Q1 | $456K | Buy |
|
|||||
|
2024
Q4 | $706K | Buy |
|
|||||
|
2024
Q3 | $1.12M | Sell |
|
|||||
|
2024
Q2 | $1.07M | Buy |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $1.67M | Sell |
|
|||||
|
2023
Q3 | $1.29M | Buy |
|
|||||
|
2023
Q2 | $1.86M | Buy |
|
|||||
|
2023
Q1 | $2.23M | Buy |
|
|||||
|
2022
Q4 | $1.93M | Buy |
|
|||||
|
2022
Q3 | $2.65M | Buy |
|
|||||
|
2022
Q2 | $1.85M | Buy |
|
|||||
|
2022
Q1 | $2.26M | Buy |
|
|||||
|
2021
Q4 | $2.15M | Buy |
|
|||||
|
2021
Q3 | $1.95M | Buy |
|
|||||
|
2021
Q2 | $2.15M | Buy |
|
|||||
|
2021
Q1 | $1.74M | Buy |
|
|||||
|
2020
Q4 | $1.68M | Buy |
|
|||||
|
2020
Q3 | $1.56M | Buy |
|